These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 27087457)

  • 21. Fatigue and depression in multiple sclerosis: pharmacological and non-pharmacological interventions.
    Brenner P; Piehl F
    Acta Neurol Scand; 2016 Sep; 134 Suppl 200():47-54. PubMed ID: 27580906
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacological treatments for fatigue associated with palliative care.
    Peuckmann V; Elsner F; Krumm N; Trottenberg P; Radbruch L
    Cochrane Database Syst Rev; 2010 Nov; (11):CD006788. PubMed ID: 21069692
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amantadine for fatigue in multiple sclerosis.
    Taus C; Giuliani G; Pucci E; D'Amico R; Solari A
    Cochrane Database Syst Rev; 2003; (2):CD002818. PubMed ID: 12804439
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Psychometric properties of the Fatigue Severity Scale and the Modified Fatigue Impact Scale.
    Learmonth YC; Dlugonski D; Pilutti LA; Sandroff BM; Klaren R; Motl RW
    J Neurol Sci; 2013 Aug; 331(1-2):102-7. PubMed ID: 23791482
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the effects of amantadine and ondansetron in treatment of fatigue in patients with multiple sclerosis.
    Khazaei M; Karevan A; Taheri M; Ghafouri-Fard S
    Clin Transl Med; 2019 Jul; 8(1):20. PubMed ID: 31263986
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patient education for people with multiple sclerosis-associated fatigue: A systematic review.
    Wendebourg MJ; Heesen C; Finlayson M; Meyer B; Pöttgen J; Köpke S
    PLoS One; 2017; 12(3):e0173025. PubMed ID: 28267811
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Validity and reliability of Persian version of Modified Fatigue Impact Scale (MFIS) questionnaire in Iranian patients with multiple sclerosis.
    Ghajarzadeh M; Jalilian R; Eskandari G; Ali Sahraian M; Reza Azimi A
    Disabil Rehabil; 2013 Aug; 35(18):1509-12. PubMed ID: 23237227
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential diagnosis and management of fatigue in multiple sclerosis: considerations for the nurse.
    Costello K; Harris C
    J Neurosci Nurs; 2003 Jun; 35(3):139-48. PubMed ID: 12830661
    [TBL] [Abstract][Full Text] [Related]  

  • 29. StressModEx--Physiotherapist-led Stress Inoculation Training integrated with exercise for acute whiplash injury: study protocol for a randomised controlled trial.
    Ritchie C; Kenardy J; Smeets R; Sterling M
    J Physiother; 2015 Jul; 61(3):157. PubMed ID: 26092388
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiple sclerosis-related fatigue.
    MacAllister WS; Krupp LB
    Phys Med Rehabil Clin N Am; 2005 May; 16(2):483-502. PubMed ID: 15893683
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term effects of Bio-Electromagnetic-Energy Regulation therapy on fatigue in patients with multiple sclerosis.
    Haase R; Piatkowski J; Ziemssen T
    Altern Ther Health Med; 2011; 17(6):22-8. PubMed ID: 22314716
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of fatigue in patients with multiple sclerosis.
    Zifko UA
    Drugs; 2004; 64(12):1295-304. PubMed ID: 15200345
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of exercising at minimum recommendations of the multiple sclerosis exercise guideline combined with structured education or attention control education - secondary results of the step it up randomised controlled trial.
    Coote S; Uszynski M; Herring MP; Hayes S; Scarrott C; Newell J; Gallagher S; Larkin A; Motl RW
    BMC Neurol; 2017 Jun; 17(1):119. PubMed ID: 28646860
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A longitudinal study on effects of a six-week course for energy conservation for multiple sclerosis patients.
    Sauter C; Zebenholzer K; Hisakawa J; Zeitlhofer J; Vass K
    Mult Scler; 2008 May; 14(4):500-5. PubMed ID: 18208883
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fatigue therapy in multiple sclerosis: results of a double-blind, randomized, parallel trial of amantadine, pemoline, and placebo.
    Krupp LB; Coyle PK; Doscher C; Miller A; Cross AH; Jandorf L; Halper J; Johnson B; Morgante L; Grimson R
    Neurology; 1995 Nov; 45(11):1956-61. PubMed ID: 7501140
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The relationship between physical activity and symptoms of fatigue, mood, and perceived cognitive impairment in adults with multiple sclerosis.
    Mayo CD; Miksche K; Attwell-Pope K; Gawryluk JR
    J Clin Exp Neuropsychol; 2019 Sep; 41(7):715-722. PubMed ID: 31096850
    [No Abstract]   [Full Text] [Related]  

  • 37. A novel cognitive-behavioral stress management method for multiple sclerosis. A brief report of an observational study.
    Anagnostouli M; Babili I; Chrousos G; Artemiadis A; Darviri C
    Neurol Res; 2019 Mar; 41(3):223-226. PubMed ID: 30451648
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Erratum.
    Mult Scler; 2016 Oct; 22(12):NP9-NP11. PubMed ID: 26041800
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Randomised controlled trial of a self-guided online fatigue intervention in multiple sclerosis.
    Pöttgen J; Moss-Morris R; Wendebourg JM; Feddersen L; Lau S; Köpke S; Meyer B; Friede T; Penner IK; Heesen C; Gold SM
    J Neurol Neurosurg Psychiatry; 2018 Sep; 89(9):970-976. PubMed ID: 29549193
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of exercise training in adults with multiple sclerosis with severe mobility disability: A systematic review and future research directions.
    Edwards T; Pilutti LA
    Mult Scler Relat Disord; 2017 Aug; 16():31-39. PubMed ID: 28755682
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.